CD19 CAR T-Cell(CAT19T2)
2022-KY-094
Phase 2 mab terminated
Quick answer
CD19 CAR T-Cell(CAT19T2) for B-cell Acute Lymphoblastic Leukemia is a Phase 2 program (mab) at Zhujiang Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zhujiang Hospital
- Indication
- B-cell Acute Lymphoblastic Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated